4Heal Technology Secures Multi-Million Dollar Pre-Seed Funding for Web3 Healthcare AI Platform

ProxyCollector · 2026-02-10T03:08:58+00:00

4Heal Technology secures a pre-seed funding round worth millions, achieving a valuation of $35 million dollars. Backed by Aimei Health Technology II, the investment aims to enhance AI health agents, develop decentralized infrastructure, and establish a secure health data commercialization platform, signaling a transformative shift in digital health.

ProxyCollector

2026-02-10 03:08:58

Abstract generation in progress

Digital health technology company 4Heal Technology successfully closed a pre-seed funding round worth millions of dollars, with the company’s valuation reaching $35 million. This strategic move marks an important milestone in the development of blockchain- and AI-based health solutions.

Exclusive Investment from Aimei Health Technology II

According to a report from Foresight News, this pre-seed funding round was exclusively supported by Aimei Health Technology II, a company listed on Nasdaq. This investment commitment reflects strong confidence in 4Heal Technology’s vision to transform the digital health ecosystem through Web3 technology.

Development of AI Agents and Decentralized Infrastructure

The funds raised will be strategically allocated to drive the development of several key initiatives. First, the company will focus on building AI-based health agents capable of providing personalized and responsive healthcare services. Second, investments will support the development of a decentralized physical infrastructure network (DePIN), bringing hardware innovation into the digital health ecosystem. Third, 4Heal Technology will build a decentralized platform specifically to facilitate the commercialization of anonymous and secure health data.

Long-term Vision for Web3 Health

With this pre-seed funding, 4Heal Technology is ready to enter a more mature development phase. The combination of advanced AI technology and blockchain decentralization principles opens new opportunities in health data privatization and digital medical innovation acceleration. The pre-seed funding strategy reflects investor confidence that Web3 health platforms will become a transformative industry category.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.